Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
A director at Stepan Co gave away/sold 15,628 shares at 0.000USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
GLR BUYOUT!: SYNT Estimates Raised and Earnings Reported: GNTX, JBT, LKQ, SCL, WAB Estimates Lowered and Earnings Reported: POL Earnings Reported: AIT, LECO, MTD Estimates Lowered: THO News: ATR, MTD, NEOG Coming Events: CDW, SMG
Our 2018 EPS estimate is now $4.79 (from $4.76), up 3% from a record 2017, aided by recaptured polymer share and repurchases, partially offset by weaker pricing in Polymers. For 2019, our EPS estimate is now $5.45 (from $5.37), up 14% from our 2018 estimate. 2Q18 (June) adjusted EPS was $1.38 (vs $1.32 a year earlier), 1 cent under our projection.
1Q18 (Mar) adjusted EPS was $1.37 (vs $1.36 year earlier), 10 cents under our projection due to weakness in Polymers (24% of sales) from increased competition and weather-related project delays; Our 2018 EPS estimate is now $4.76 (from $5.06), up 2% from a record 2017; For 2019, our EPS estimate is now $5.37 (from $5.63), up 13% from our 2018 estimate.
4Q17 (Dec) adjusted EPS were $1.06 (vs $0.52 a year earlier) and 24 cents above our projection due to higher sales from pricing on raw material cost pass-throughs and a lower tax rate; For 2017, EPS was $4.65 (vs $4.24), up 10% from 2016; Our 2018 EPS estimate is now $5.06 (from $4.62 – which was not adjusted for the new U.S. tax law), up 9% from 2017; For 2019, our EPS estimate is being introduced at $5.63, up 11% from our 2018 estimate.
3Q17 (Sept) adjusted EPS were $0.92 (vs $1.10 a year earlier) and 22 cents below our projection due to lower volumes in the Polymer segment and higher raw material costs; For 2017, our EPS estimate is now $4.42 (from $4.70), up 4% from 2016, impacted by increased competition in Polymers and rising raw material costs, partially offset by price increases and efficiency gains; Our 2018 EPS estimate is now $4.62 (from $5.22), up 5% from our 2017 estimate; Stepan increased its quarterly dividend...
2Q17 (June) adjusted EPS were $1.32 (vs $1.33 a year earlier) and 2 cents below our projection due to lower volumes and higher raw material costs in the Polymer segment; For 2017, our EPS estimate is now $4.70 (from $4.72), up 12% from 2016, aided by continued efficiency gains, cost savings, and the lack of 2016’s unusual expenses, partially offset by increased competition in Polymers and rising raw material costs; Our 2018 EPS estimate is now $5.22 (from $5.29), up 11% from our 2017 estimat...
EPS is projected up 13% to a record $4.72 in 2017 (despite an expected flat 1Q) and a further 12% in 2018, aided by growth in Polymers (28% of sales), cost reductions, and a lack of unusual costs that occurred in 2016. Covered by only two other sell-side firms, the thinly traded shares have significant discovery potential. The dividend has been increased for 49 consecutive years, a feat achieved by only 26 other public companies. Insiders own around 12% of the shares.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.